Vaxcyte, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
PCVX Nasdaq 2830 vaxcyte.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Vaxcyte, Inc.

Vaxcyte Reports Second Quarter 2026 Financial Results and Provides Business Update - Aug 5th, 2026 2:05 pm
Vaxcyte to Participate in Upcoming Investor Conferences - Jul 8th, 2026 2:05 pm
Vaxcyte Inc (PCVX) Is A Hidden Multibagger Stock To Buy Now - Jul 3rd, 2026 7:41 am
Vaxcyte (PCVX) Doses Its First Patient in a Trial for a Disease With No Existing Vaccine - Jun 22nd, 2026 8:14 am
Vaxcyte (PCVX) Conducts Initial Dosage for VAX-A1 Phase 1 Study - Jun 17th, 2026 9:55 am
Pneumonia Market Set to Witness Robust Growth During the Forecast Period (2026-2036), Driven by Advancing Therapeutics and Rising Disease Burden | DelveInsight - Jun 8th, 2026 8:01 am
Trevi Therapeutics Is Up 100%, Pivotal bioVenture Adds Anyway. Here's Why That Matters. - Jun 3rd, 2026 8:04 am
Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults - Jun 2nd, 2026 2:05 pm
Why Vaxcyte (PCVX) Is Up 8.7% After Completing Key VAX-31 Phase 3 Trial Enrollments - Jun 1st, 2026 12:12 am
Vaxcyte (PCVX) Completes Enrollment for Phase 3 VAX-31 Clinical Trials - May 29th, 2026 12:40 am
This Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 Million - May 24th, 2026 8:39 am
This Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last Quarter - May 24th, 2026 8:33 am
How S&P Drug Titan Pfizer Plans To Outdo Its Own $6 Billion Franchise - May 20th, 2026 2:10 pm
Dyne Therapeutics Is Up 40%, but One Biotech Fund Just Disclosed Selling $14 Million Worth of Shares - May 19th, 2026 11:37 am
What This Fund’s $14 Million Ocular Therapeutix Exit Could Signal for Investors - May 19th, 2026 11:26 am
Biotech Fund Sells $44.5 Million Erasca Stake After Massive 700% Rally - May 18th, 2026 2:00 pm
Vaxcyte Reports First Quarter 2026 Financial Results and Provides Business Update - May 6th, 2026 2:05 pm
Vaxcyte Inc (PCVX)’s VAX-31 Enters Critical Trial Stage - Apr 23rd, 2026 3:47 am
Is It Too Late To Consider Vaxcyte (PCVX) After A 95% One-Year Share Price Jump? - Apr 10th, 2026 9:11 pm
Vaxcyte to Present at the 25th Annual Needham Virtual Healthcare Conference - Apr 7th, 2026 2:05 pm